What is VBIZF's gross margin?

Viva Biotech (VBIZF) has a gross margin of 34% and a net margin of 8%.

What is VBIZF's P/E ratio?

VBIZF's P/E ratio is 15.5 with ROE of 9%.

Where can I see VBIZF's full financials?

See Viva Biotech (VBIZF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Viva Biotech (VBIZF) Financials — Revenue, Earnings, Cash Flow

Also trades as: 1873.HK (HKSE) · $vol 1M

$0.19

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 57 · $397.7M mcap · 1.01B float · 0.0001% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$4B

Revenue

-15.5% YoY

$349M

Net Income

+179.9% YoY

$505M

Free Cash Flow

+26.2% YoY

34.0%

Gross Margin

11.1%

Op. Margin

8.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE9.0%

ROA5.0%

ROIC8.9%

Valuation

P/E15.5

P/B0.7

EV/EBITDA0.0

Leverage

Debt/Equity0.23

Current Ratio1.54

Interest Cov.7.7x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M-3.16